SPINK1 also functions as a prognostic marker in colorectal cancer, gastric cancer, and renal cell carcinoma (16–18), with differential expression observed across multiple solid tumors, including but not limited to ovarian cancer, bladder cancer, gallbladder cancer, lung cancer, and breast cancer (19–22). Here, SPINK1 is linked to colorectal cancer.